Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04972916 · ClinicalTrials.gov registry record · NA
Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients
A NA study of Tobacco Use, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT04972916: Completed NA study of Tobacco Use, sponsored by Milton S. Hershey Medical Center.
NCT04972916 is a NA study of Tobacco Use that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 12 participants, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04972916, a NA study of Tobacco Use, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the feasibility and preliminary efficacy of patient navigation to promote linkage to smoking cessation treatments in cancer patients.
Primary Outcome
This outcome is measured by the ability to recruit and enroll 20 participants for the 2-month program, individual participant attendance in patient navigation intervention visits, and completion of final assessment.
Conditions Studied
Interventions
- OTHER Patient navigation-based tobacco harm reduction intervention
Study Locations (1)
Pennsylvania
- Penn State Cancer Institute - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT04972916 record still lists
NCT04972916 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Patient navigation-based tobacco harm reduction intervention is the first listed.
NCT04972916 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04972916 about?
NCT04972916 is a clinical study titled "Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients". The purpose of this study is to examine the feasibility and preliminary efficacy of patient navigation to promote linkage to smoking cessation treatments in cancer patients.
What is the current status of trial NCT04972916?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-06-15. Estimated completion is 2021-12-31.
What conditions does trial NCT04972916 study?
This clinical trial studies the following conditions: Tobacco Use.
What interventions are being tested in trial NCT04972916?
The interventions under investigation include: Patient navigation-based tobacco harm reduction intervention (OTHER).
Who is sponsoring clinical trial NCT04972916?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04972916 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04972916's enrollment target sits among peer trials
12 74th of 76 higher than 3 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI